U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

NCT06069661 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped moving directly into the Pivotal study

Conditions

Interventions

Sponsor

EnCompass Technologies, Inc.